The inherent risk of a market that is transitioning from analog to digital Significant exposure to silver costs Good market position in medical and dental film Very aggressive financial policy, characterized by a sizable debt burden Consistently good free cash flow generation The outlook is stable. We expect that high-teen EBITDA margins and disciplined capital spending will enable Carestream Health Inc. to continue generating good free operating cash flow of about $150 million. We expect Carestream will maintain debt to EBITDA of about 5x and funds from operations (FFO) to debt of about 10% to 12% over the next 12 months. We could lower the rating if the company's operating performance weakens. This could happen, for instance, if raw material
